| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/30/2011 | EP2301566A1 DNA vaccines encoding heat shock proteins |
| 03/30/2011 | EP2301558A1 Preventative and/or therapeutic agent against atopic dermatitis |
| 03/30/2011 | EP2301553A1 Polynucleotide therapy |
| 03/30/2011 | EP2301552A1 Polynucleotide therapy |
| 03/30/2011 | EP2301549A1 Remedies for diseases to be applied to eye |
| 03/30/2011 | EP2301539A1 PPAR gamma agonists for treating illnesses with pathophysiological participation of TH17 lymphocytes |
| 03/30/2011 | EP2301534A1 Amino-methyl substituted tetracycline compounds |
| 03/30/2011 | EP2301528A1 Use of FTS for treating malignant disorders |
| 03/30/2011 | EP2301343A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 03/30/2011 | EP2300602A1 Method to induce and expand therapeutic alloantigen- specific human regulatory t cells in large-scale |
| 03/30/2011 | EP2300485A1 Pyrrolo ý2, 3-c¨pyridine derivatives as p38 kinase inhibiting agents |
| 03/30/2011 | EP2300469A2 Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
| 03/30/2011 | EP2300459A1 Novel phenylpyrazinones as kinase inhibitors |
| 03/30/2011 | EP2300102A2 Long term disease modification using immunostimulatory oligonucleotides |
| 03/30/2011 | EP2300026A2 Compositions obtained from chlorella extract having immunomodulating properties |
| 03/30/2011 | EP2300000A1 Methods and compositions for reducing inflammation and treating inflammatory disorders |
| 03/30/2011 | EP2121736B1 New anti-malaria vaccine compositions and uses thereof |
| 03/30/2011 | EP1503773B1 Hepatoprotective activity of 2 -p-hydroxybenzoylmussaenosidic acid |
| 03/30/2011 | EP1500698B1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport |
| 03/30/2011 | EP1409006B1 Monodispersed mixtures and methods of treating diabetes |
| 03/30/2011 | CN1872058B Medication composition of containing macrolides |
| 03/30/2011 | CN1780855B Human il-1 beta antagonists |
| 03/30/2011 | CN101998966A Methods of using cadherin 11 (CDH11) antagonists |
| 03/30/2011 | CN101998965A Immunosuppressive polypeptides and nucleic acid |
| 03/30/2011 | CN101998958A Thieno-and furo-pyrimidine modulators of the histamine h4 receptor |
| 03/30/2011 | CN101998857A Wet granulation using a water sequestering agent |
| 03/30/2011 | CN101993888A Method for producing and recombining main allergic protein Hum j 3 of Humulus scandens by induced secretion expression |
| 03/30/2011 | CN101993497A Human proliferation-inducing ligand blocking agent and preparation method and application thereof |
| 03/30/2011 | CN101993281A Culture medium of ganoderma capense (Lloyd) Teng fungus for preparing Baozhi glycopeptide injection |
| 03/30/2011 | CN101991880A Preparation consisting of PLGA (Polylactic Acid-Polyglycolic Acid)/TCP (Tris Calcium Polymer) and MSC (Mesenchymal Stem Cells) of compound MSC and application thereof |
| 03/30/2011 | CN101991878A Preparation consisting of PLGA (Polylactic Acid-Polyglycolic Acid) and MSC (Mesenchymal Stem Cells) of compound MSC and application thereof |
| 03/30/2011 | CN101991850A Preparation technology of nanometer aluminum hydroxide adjuvant |
| 03/30/2011 | CN101991831A Medicine, preparation method thereof, as well as application thereof in treatment on allergic rhinitis |
| 03/30/2011 | CN101991818A Medicament for treating and resisting allergic diseases |
| 03/30/2011 | CN101991767A Stomach strengthening and kidney nourishing traditional Chinese medicine oral liquid |
| 03/30/2011 | CN101991713A Medicament containing raw materials of Pu'er tea and worm grass |
| 03/30/2011 | CN101991649A Medicament for treating allergic rhinitis |
| 03/30/2011 | CN101991633A Method for extracting tripterygium glycosides, and product and inclusion compound and medicinal composition thereof |
| 03/30/2011 | CN101991628A Process for preparing non-toxic extractive from asarum heterotropoides |
| 03/30/2011 | CN101991614A Compound fermented cordyceps sinensis powder (paecilomyces hepiali Cs-4 bacterial powder) combined medicine and preparation thereof |
| 03/30/2011 | CN101991612A Preparation method of haematococcus pluvialis extracts |
| 03/30/2011 | CN101991609A Efficient three-in-one royal jelly soft capsule |
| 03/30/2011 | CN101991606A Preparation method of solid water-soluble lead-removed propolis |
| 03/30/2011 | CN101991575A Application of evodiamine in preparing medicine for inhibiting aryl hydrocarbon receptor |
| 03/30/2011 | CN101991574A Desloratadine external preparation and preparation method thereof |
| 03/30/2011 | CN101991566A Application of lariciresinol to preparing medicament for resisting autoimmune disease and graft rejection disease |
| 03/30/2011 | CN101991548A Reduced glutathione freeze-dried powder injection and preparation method thereof |
| 03/30/2011 | CN101991547A Preparation method of sodium ferulate freeze-dried powder injection |
| 03/30/2011 | CN101991532A Self-microemulsion composition, microemulsion and preparation methods thereof |
| 03/30/2011 | CN101991099A Ginseng can |
| 03/30/2011 | CN101486681B Method for producing azathiopurine intermediate and product produced thereby |
| 03/30/2011 | CN101375839B Grifola frondosa polysaccharide soft capsules and preparation method thereof |
| 03/30/2011 | CN101244259B Thymus gland peptide alpha1sustained-release microsphere preparation for injection and preparation thereof |
| 03/30/2011 | CN101244110B Preparation method of Chinese medicine composition with function of releasing fatigue, reinforcing immunity |
| 03/30/2011 | CN101199836B Stage releasing CsA solid tiny milk agent and tiny milk curing method thereof |
| 03/30/2011 | CN101112448B Donkey-hide gelatin composition having immunity improving effect and method of making the same |
| 03/29/2011 | US7915310 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 03/29/2011 | US7915291 Hepatitis C virus inhibitors |
| 03/29/2011 | US7915280 Compounds and their uses |
| 03/29/2011 | US7915265 Combinations for the treatment of immunoinflammatory disorders |
| 03/29/2011 | US7915264 Drugs for treating pain formed by arylation |
| 03/29/2011 | US7915237 Production of pure stereoisomers of tricyclo[5.2.1.02.6]-dec-9-yl-xanthogenate and medicaments therefrom |
| 03/29/2011 | US7915234 Pharmaceutically active uridine esters |
| 03/29/2011 | US7915009 Modulating NF-kappa B by administering antigens or polynucleotide encoding antigens, antibody; treating cancer, tumor, Alzheimer's disease or a spongiform encephalopathy; DNA vaccine in kits |
| 03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
| 03/29/2011 | CA2483752C Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| 03/29/2011 | CA2472114C 2-o-(.beta.-d-glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containing compositons comprising it |
| 03/29/2011 | CA2462211C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 03/29/2011 | CA2460640C Diaryl ether derivatives, salts thereof and immunosuppressive agents using the same |
| 03/29/2011 | CA2436980C Amido ether substituted imidazoquinolines |
| 03/29/2011 | CA2435730C Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 03/29/2011 | CA2435146C Formulation of boronic acid compounds |
| 03/29/2011 | CA2397016C Use of lipid conjugates in the treatment of disease |
| 03/29/2011 | CA2390652C Human circulating virus-inhibiting peptide (virip) and its use |
| 03/29/2011 | CA2390164C Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/29/2011 | CA2379508C Biphasic skin composition comprising ascorbic acid, ceramides and betaglycane |
| 03/29/2011 | CA2279407C Centipeda plant extract |
| 03/29/2011 | CA2263798C G-coupled receptor showing selective affinity for atp |
| 03/29/2011 | CA2252438C Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
| 03/24/2011 | WO2011035018A2 Suicide ready cells |
| 03/24/2011 | WO2011034896A2 Small molecule inhibitors of the alpha4-paxillin interaction |
| 03/24/2011 | WO2011034504A1 Solid forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and methods of making the same |
| 03/24/2011 | WO2011034465A1 A pharmaceutical composition for peroral administration of diindolylmethane |
| 03/24/2011 | WO2011034328A2 Composition including chlorophyll a as an active ingredient for preventing and treating th2-mediated immunological diseases |
| 03/24/2011 | WO2011034078A1 Glycine compound |
| 03/24/2011 | WO2011033053A1 Macrocyclic inhibitors of jak |
| 03/24/2011 | WO2011032633A1 Treatment of autoimmune and inflammatory diseases with epratuzumab |
| 03/24/2011 | WO2011032229A1 A novel epsilon polymorphic form of inulin and compositions comprising same |
| 03/24/2011 | WO2011032204A1 Treatment of neurological conditions |
| 03/24/2011 | WO2010096385A3 Methods and compositions for the treatment of autoimmune disease |
| 03/24/2011 | WO2010022358A8 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazolo[4,5- c]pyridinyl)purine and purinone derivatives for immunosuppression |
| 03/24/2011 | US20110071499 Free-standing biodegradable patch |
| 03/24/2011 | US20110071498 Free-standing biodegradable patch |
| 03/24/2011 | US20110071210 Methods and compositions for the treatment of cancer or other diseases |
| 03/24/2011 | US20110071197 Bis-aryl compounds for use as medicaments |
| 03/24/2011 | US20110071196 Compounds Which Selectively Modulate The CB2 Receptor |
| 03/24/2011 | US20110071184 Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder |
| 03/24/2011 | US20110071159 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament |
| 03/24/2011 | US20110071149 Selective kinase inhibitors |
| 03/24/2011 | US20110071144 Quinazoline derivatives and pharmaceutical compositions containing them |